OFIX

Orthofix Medical Inc. Common Stock (DE)

OFIX
Closed
$11.48
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,605 full-time employees. The company offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The company provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Country

US

CEO

Mr. Massimo Calafiore

IPO date

1992

Employees

1,605

ISIN

US68752M1080

Key stats

Open

$11.48

Volume

272.95K

Market cap

$466.47M

Prev. close

$11.48

Impl / hst vl

-

Open interest

$0.00

$11.32

Day’s Range

$11.61

$8.85

52W Range

$16.42

Valuation

66
Valuation score
Undervalued
P/E
-
P/S
0.56
P/B
1.07
Current ratio
2.87
Debt / Equity
0.26
ROE
-13.44%
Gross margin
70.94%
Income growth
840.95%
FCF growth
-268.08

Analysts estimates

Consensus rating
Strong buy

The average rating from top 4 analysts indicates that stock may significantly outperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$15.30
The top 6 analysts forecasts that 12-month price may increase by 33.28%, with a low of $12.12 and a high of $18.90
$12.12
Low
$15.30
Avg
$18.90
High
Current price

Earnings

Q1 ‘26 revenue
$196.71M
Q1 ‘26 net income
-$20.91M
Revenue
Net income
Previous EPS
-$0.13
Estimate EPS
-$0.42
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply